USPTO serial 88731294
SLAYBACK PHARMA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Apr 20, 2021
- Examiner
- MARTIN, LIEF ANDREW
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with SLAYBACK PHARMA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $399*
Plus Government fees of $325
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Douglas R. Wolf
Douglas R. Wolf Wolf Greenfield & Sacks, P.C.600 Atlantic AvenueBoston, MA 02210United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | pharmaceutical drugs, preparations and medications for use in the prevention, reduction and treatment of cardiovascular disorders, allergies, anaphylaxis, central nervous system disorders, peripheral nervous system disorders, reproductive health disorders, electrolytic imbalance, caloric imbalance, obesity, nutritional disorders, autoimmune disorders, endocrine disorders, gastrointestinal disorders, inflammatory disorders, dermatological disorders, infectious diseases, hormonal imbalance, pain, complications arising from organ transplantation, cancer, pulmonary disorders, renal disorders, urinary system disorders, ophthalmic disorders, otic disorders, sense organ disorders, dental disorders, musculoskeletal disorders, diabetic disorders, neuromuscular disorders, bone disorders, blood disorders, metabolic disorders, psychosis; pharmaceutical drugs, preparations and medications for use in sedation, analgesia, anaesthesia; pharmaceutical drugs, preparations and medications for use in the prevention, reduction and treatment of senile disorders, sleep disorders, dementia, congenital disease disorders, abnormal gene disorders, hair growth disorders, gynaecological diseases, obstetric disorders, withdrawal syndromes, hormonal disorders, urogenital organ disorders, sexual dysfunction, nausea and vomiting, emesis, migraine, edema, multiple sclerosis, chronic obstructive pulmonary disorder, depression, pregnancy, spasms, hypertension, hypotension, angioedema, fungal diseases, fertility disorders, hyperglycemia, hypoglycemia, post-operative disorders, arthritis, psoriasis and localized fat deposits; pharmaceutical and biological preparations for use in diagnosis, namely, for use as X-ray contrast reagents | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Slayback Pharma Limited Liability Company
- Other trademarks owned by AZURITY PHARMACEUTICALS, INC.
- Other trademarks owned by Slayback Pharma Limited Liability Company
- Other trademarks in Class 005
- Similar marks named SLAYBACK PHARMA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 20, 2026 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Mar 19, 2025 | ASCK | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | — |
| Mar 5, 2025 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Jul 16, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 16, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 16, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jul 16, 2024 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jul 16, 2024 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Apr 20, 2021 | R.SR | REGISTERED-SUPPLEMENTAL REGISTER | Your mark is registered on the Supplemental Register, which is available for marks that are not yet distinctive enough for the Principal Register but can still identify a source. Protection is more limited than Principal Register registration but can later support a Principal Register application. |
| Mar 18, 2021 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Mar 17, 2021 | ALIE | ASSIGNED TO LIE | — |
| Mar 17, 2021 | CNTA | APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER | — |
| Mar 16, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 15, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 15, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 13, 2021 | AAUA | NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED | — |
| Mar 12, 2021 | IUAA | USE AMENDMENT ACCEPTED | — |
| Feb 12, 2021 | AUPC | AMENDMENT TO USE PROCESSING COMPLETE | — |
| Feb 12, 2021 | IUAF | USE AMENDMENT FILED | — |
| Feb 11, 2021 | EAAU | TEAS AMENDMENT OF USE RECEIVED | — |
| Sep 24, 2020 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 24, 2020 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 24, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 21, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 21, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 21, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 21, 2020 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 21, 2020 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 21, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 20, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 21, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 21, 2019 | NWAP | NEW APPLICATION ENTERED | — |